ECTRIMS 2017

Drug May Slow Conversion to Definite MS From Clinically Isolated Syndrome

Drug May Slow Conversion to Definite MS From Clinically Isolated Syndrome

By

Aubagio may cause delays in conversion to clinical definite MS by slowing the loss of cortical grey matter.

Switch to Alemtuzumab Reduces MS Disease Activity

Switch to Alemtuzumab Reduces MS Disease Activity

By

Patients experienced reduced disease activity when switched to alemtuzumab.

Disability Progression Slowed in Relapsing MS With Ocrelizumab Treatment

Disability Progression Slowed in Relapsing MS With Ocrelizumab Treatment

By

Data show superiority of OCREVUS compared to Rebif in reducing disability progression independent of relapse activity in people with RMS.

Novel Multiple Sclerosis Drug Shows Promise

Novel Multiple Sclerosis Drug Shows Promise

By

Celgene announced new Phase 3 data evaluating the safety and efficacy of ozanimod vs Avonex for RMS.

Fingolimod Promising for Pediatric Relapsing Multiple Sclerosis

Fingolimod Promising for Pediatric Relapsing Multiple Sclerosis

By

There are no FDA-approved MS therapies for the pediatric population.

Comorbidities May Increase Relapse Risk in Multiple Sclerosis

Comorbidities May Increase Relapse Risk in Multiple Sclerosis

By

An emerging line of inquiry suggests a potential association between comorbidities and MS relapses, but studies have been limited.

OSA Screening Advised for Fatigued Patients With MS

OSA Screening Advised for Fatigued Patients With MS

By

Patients with multiple sclerosis who experience severe fatigue should be screened for obstructive sleep apnea.

Multiple Sclerosis Lesion Location Linked to Hyperalgesia, Hypoalgesia

Multiple Sclerosis Lesion Location Linked to Hyperalgesia, Hypoalgesia

By

In patients with multiple sclerosis, lesions in the right dorsolateral prefrontal cortex may be associated with hypoalgesia, and lesions in the posterior periventricular area, with hyperalgesia.

Earlier Onset of Multiple Sclerosis Linked to Cesarean Delivery, Artificial Lactation

Earlier Onset of Multiple Sclerosis Linked to Cesarean Delivery, Artificial Lactation

By

Researchers believe that environmental factors may impact disease severity characteristics in genetically susceptible populations.

Detecting Cognitive Decline in Multiple Sclerosis With Shortened BICAMS

Detecting Cognitive Decline in Multiple Sclerosis With Shortened BICAMS

By

With its 20-minute application time, the BICAMS is one of the few tools available for small centers with only a few staff members who might not be trained in administering neuropsychological tests.

Vitamin D Levels in Multiple Sclerosis Impact Epstein-Barr Viral Load

Vitamin D Levels in Multiple Sclerosis Impact Epstein-Barr Viral Load

By

Viral load of Epstien-Barr virus and human herpesvirus 6 may be higher in patients with MS who also have low vitamin D levels.

Sign Up for Free e-newsletters

CME Focus